Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Sniderman

Showing results (21-30 of 164) with videos related to

Pageof 17
Sort By:
Journal of the American College of Cardiology|July 19, 2008
We must prevent disease, not predict eventsAllan D Sniderman
Current Opinion in Lipidology|November 13, 2007
Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndromeAllan D Sniderman, May Faraj
Current Opinion in Endocrinology, Diabetes, and Obesity|November 24, 2020
Apolipoprotein B: the Rosetta Stone of lipidologyTamara Glavinovic, Allan D Sniderman
BMC Medicine|March 2, 2013
Do statins lower testosterone and does it matter?Allan D Sniderman, George Thanassoulis
Current Opinion in Cardiology|November 7, 2023
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular careSelin Bilgic, Allan D Sniderman
European Journal of Preventive Cardiology|June 9, 2026
Rethinking Cardiovascular Prevention in the Era of AIAllan D Sniderman, Michael Pencina
The New England Journal of Medicine|December 14, 2016
Variants in ANGPTL4 and the Risk of Coronary Artery DiseaseAllan D Sniderman, George Thanassoulis
Circulation|April 3, 2023
Cholesterol, Coronary Calcification, and Cardiovascular Prevention: Lessons We Can Learn From the Western Denmark Heart RegistryElie Akl, Allan D Sniderman
Journal of Clinical Epidemiology|May 1, 2012
Pluralism of viewpoints as the antidote to intellectual conflict of interest in guidelinesAllan D Sniderman, Curt D Furberg
Lancet (London, England)|March 7, 2008
Age as a modifiable risk factor for cardiovascular diseaseAllan D Sniderman, Curt D Furberg
Pageof 17

Showing results (21-30 of 164) with videos related to

Sort By:
Pageof 17
Journal of the American College of Cardiology|July 19, 2008
We must prevent disease, not predict eventsAllan D Sniderman
Current Opinion in Lipidology|November 13, 2007
Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndromeAllan D Sniderman, May Faraj
Current Opinion in Endocrinology, Diabetes, and Obesity|November 24, 2020
Apolipoprotein B: the Rosetta Stone of lipidologyTamara Glavinovic, Allan D Sniderman
BMC Medicine|March 2, 2013
Do statins lower testosterone and does it matter?Allan D Sniderman, George Thanassoulis
Current Opinion in Cardiology|November 7, 2023
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular careSelin Bilgic, Allan D Sniderman
European Journal of Preventive Cardiology|June 9, 2026
Rethinking Cardiovascular Prevention in the Era of AIAllan D Sniderman, Michael Pencina
The New England Journal of Medicine|December 14, 2016
Variants in ANGPTL4 and the Risk of Coronary Artery DiseaseAllan D Sniderman, George Thanassoulis
Circulation|April 3, 2023
Cholesterol, Coronary Calcification, and Cardiovascular Prevention: Lessons We Can Learn From the Western Denmark Heart RegistryElie Akl, Allan D Sniderman
Journal of Clinical Epidemiology|May 1, 2012
Pluralism of viewpoints as the antidote to intellectual conflict of interest in guidelinesAllan D Sniderman, Curt D Furberg
Lancet (London, England)|March 7, 2008
Age as a modifiable risk factor for cardiovascular diseaseAllan D Sniderman, Curt D Furberg
Pageof 17